Natalie Collins | Medical Services
Specialties
Programs & Services
Languages
- English
Natalie Collins | Education
Medical School
University of Virginia School of Medicine
2009, Charlottesville, VA
Internship
Boston Combined Residency Program (BCRP)
2010, Boston, MA
Residency
Pediatrics
Boston Combined Residency Program (BCRP)
2011, Boston, MA
Fellowship
Pediatric Hematology-Oncology
Dana-Farber/Boston Children's Cancer and Blood Disorders
2015, Boston, MA
Natalie Collins | Certifications
- American Board of Pediatrics (General)
- American Board of Pediatrics (Hematology-Oncology)
Natalie Collins | Publications
Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics. Clin Cancer Res. 2024 Oct 01; 30(19):4363-4376. View Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics. Abstract
Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. Nat Commun. 2024 Aug 22; 15(1):7218. View Author Correction: Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. Abstract
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. Nat Commun. 2024 Jul 11; 15(1):5837. View Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. Abstract
Off-label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center. Cancer Med. 2024 Apr; 13(8):e7154. View Off-label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center. Abstract
Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics. medRxiv. 2024 Mar 11. View Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomics. Abstract
A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity. bioRxiv. 2024 Jan 16. View A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneity. Abstract
Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency. Clin Cancer Res. 2023 12 01; 29(23):4770-4783. View Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency. Abstract
Learning About Mismatch Repair From a Rare Cancer Syndrome: A LOGICal Step Forward. J Clin Oncol. 2023 02 01; 41(4):727-731. View Learning About Mismatch Repair From a Rare Cancer Syndrome: A LOGICal Step Forward. Abstract
Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer. JCO Precis Oncol. 2022 11; 6:e2200390. View Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood Cancer. Abstract
Derivation and validation of a risk classification tree for patients with synovial sarcoma. Cancer Med. 2023 01; 12(1):170-178. View Derivation and validation of a risk classification tree for patients with synovial sarcoma. Abstract
PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment. J Immunother Cancer. 2022 03; 10(3). View PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment. Abstract
Molecular Characterization of Inflammatory Tumors Facilitates Initiation of Effective Therapy. Pediatrics. 2021 12 01; 148(6). View Molecular Characterization of Inflammatory Tumors Facilitates Initiation of Effective Therapy. Abstract
Author Correction: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nat Med. 2020 Aug; 26(8):1307. View Author Correction: A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Abstract
Role of Surgery in Rhabdomyosarcoma of the Head and Neck in Children. Laryngoscope. 2021 03; 131(3):E984-E992. View Role of Surgery in Rhabdomyosarcoma of the Head and Neck in Children. Abstract
The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Pediatr Blood Cancer. 2020 10; 67(10):e28559. View The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor. Abstract
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nat Med. 2020 05; 26(5):792-802. View A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Abstract
Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers. Clin Cancer Res. 2020 06 15; 26(12):2882-2890. View Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers. Abstract
Pediatric post-transplant hepatic kaposi sarcoma due to donor-derived human herpesvirus 8. Pediatr Transplant. 2019 05; 23(3):e13384. View Pediatric post-transplant hepatic kaposi sarcoma due to donor-derived human herpesvirus 8. Abstract
Binding of FANCI-FANCD2 Complex to RNA and R-Loops Stimulates Robust FANCD2 Monoubiquitination. Cell Rep. 2019 01 15; 26(3):564-572.e5. View Binding of FANCI-FANCD2 Complex to RNA and R-Loops Stimulates Robust FANCD2 Monoubiquitination. Abstract
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. Nature. 2019 01; 565(7737):43-48. View Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. Abstract
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature. 2017 07 27; 547(7664):413-418. View In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Abstract
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity. J Exp Med. 2017 04 03; 214(4):895-904. View PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity. Abstract
Use of a fever fast track tool to reduce time to antibiotic dose in febrile pediatric oncology patients. J Clin Oncol. 2014 Oct 20; 32(30_suppl):222. View Use of a fever fast track tool to reduce time to antibiotic dose in febrile pediatric oncology patients. Abstract
ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function. Blood. 2009 Mar 05; 113(10):2181-90. View ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function. Abstract